No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / economics
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / genetics
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / genetics
-
Carcinoma, Renal Cell / mortality
-
Carcinoma, Renal Cell / pathology
-
Cost-Benefit Analysis
-
Drug Costs
-
Drug Substitution*
-
Genetic Predisposition to Disease
-
Genetic Testing / methods
-
Humans
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / genetics
-
Kidney Neoplasms / mortality
-
Kidney Neoplasms / pathology
-
Patient Selection
-
Phenotype
-
Precision Medicine
-
Predictive Value of Tests
-
Time Factors
-
Treatment Failure
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor